Sumitomo Pharma Co Ltd (TSE:4506)
円 336 -19 (-5.35%) Market Cap: 133.49 Bil Enterprise Value: 516.24 Bil PE Ratio: 0 PB Ratio: 0.85 GF Score: 49/100

Sumitomo Pharma Co Ltd ESG Meeting Transcript

Dec 13, 2022 / NTS GMT
Release Date Price: 円1043 (-0.57%)
Naoki Noguchi
Sumitomo Pharma America Holdings, Inc. - Director of Business Development

My name is Naoki Noguchi. Thank you all very much for taking the time out of your busy schedules to join us today.

Let me start with the agenda of today's meeting. Here is the table of contents. We are currently reorganizing our material issues in terms of their impact on the value we provide in accordance with our corporate mission. We would like to hear your honest opinion about our capital, in other words, strength and potential, which we consider important for rearranging the material issues and are the source of our unique value creation.

First, I would like to offer a presentation for about 15 minutes or shorter, and then we will move on to the panel discussion. Sumitomo Pharma is in the process of preparing a material issue and would like to bring our assessment to a higher-quality level. At this stage, we would like to receive candid feedback from the investors and analysts and exchange ideas.

When we first identified material issues back in FY 2018, we categorized these issues in 2

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot